TriSalus Life Sciences Ownership | Who Owns TriSalus Life Sciences?
TriSalus Life Sciences Ownership Summary
TriSalus Life Sciences is owned by 27.27% institutional investors, 42.41% insiders, and 30.32% retail investors. Nantahala capital management is the largest institutional shareholder, holding 6.20% of TLSI shares.
TLSI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | TriSalus Life Sciences | 27.27% | 42.41% | 30.32% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Medical Device Stocks | 37.80% | 10.13% | 52.07% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nantahala capital management | 2.04M | 6.20% | $9.49M |
| Awm investment company | 1.25M | 3.80% | $5.81M |
| Vanguard group | 1.16M | 3.52% | $5.39M |
| Gilder gagnon howe | 1.05M | 3.18% | $4.87M |
| Blackrock funding, inc. /de | 787.86K | 2.39% | $3.66M |
| Wealthcare advisory partners | 643.74K | 1.96% | $2.99M |
| Alyeska investment group | 557.50K | 1.69% | $2.59M |
| Geode capital management | 554.46K | 1.69% | $2.58M |
| State street | 192.63K | 0.59% | $895.74K |
| Northern trust | 176.65K | 0.54% | $821.44K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Awm investment company | 1.25M | 0.54% | $5.81M |
| Nantahala capital management | 2.04M | 0.33% | $9.49M |
| Connective capital management | 32.80K | 0.14% | $152.50K |
| Msd partners | 40.00K | 0.12% | $186.00K |
| White pine capital | 59.73K | 0.08% | $277.76K |
| Wealthcare advisory partners | 643.74K | 0.06% | $2.99M |
| Gilder gagnon howe | 1.05M | 0.05% | $4.87M |
| Cwa asset management group | 72.00K | 0.01% | $334.80K |
| Alyeska investment group | 557.50K | 0.01% | $2.59M |
| Bridgeway capital management | 69.50K | 0.01% | $323.18K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 1.16M | 0.00% | 345.19K |
| Blackrock funding, inc. /de | 787.86K | 0.00% | 166.18K |
| Goldman sachs group | 150.49K | 0.00% | 133.67K |
| Geode capital management | 554.46K | 0.00% | 99.40K |
| State street | 192.63K | - | 77.04K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Duquesne family office | - | - | -426.92K |
| Gilder gagnon howe | 1.05M | 0.05% | -45.92K |
| Morgan stanley | 17.98K | - | -38.35K |
| Renaissance | - | - | -20.20K |
| Virtu financial | - | - | -19.88K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ci private wealth | 75.70K | 0.00% | 75.70K | $352.00K |
| Squarepoint ops | 73.71K | 0.00% | 73.71K | $342.73K |
| Cwa asset management group | 72.00K | 0.01% | 72.00K | $334.80K |
| White pine capital | 59.73K | 0.08% | 59.73K | $277.76K |
| Sequoia financial advisors | 19.46K | 0.00% | 19.46K | $90.47K |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -79.00 |
| Coldstream capital management | -150.00 |
| Exos asset management | -3.60K |
| Prudential financial | -10.00K |
| Two sigma securities | -10.60K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 51 | 8.51% | 8,972,933 | 5.93% | 27 | 4.11% | 27 | -28.95% | 11 | 450.00% |
| Jun 30, 2025 | 47 | 42.42% | 8,470,337 | 187.35% | 25 | 24.11% | 38 | 72.73% | 2 | 100.00% |
| Mar 31, 2025 | 1 | -96.15% | 4,008 | -99.83% | - | 0.02% | 1 | -85.71% | - | -100.00% |
| Dec 31, 2024 | 25 | -19.35% | 2,295,289 | 5.72% | 8 | 12.90% | 7 | -50.00% | 8 | -11.11% |
| Sep 30, 2024 | 31 | 19.23% | 2,171,190 | 21.63% | 8 | 14.69% | 14 | 16.67% | 9 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 19, 2025 | Cox Bryan F. | Chief of Research | Sell | $24.68K |
| May 19, 2025 | Devlin Jodi | Chief of Clinical Operations | Sell | $24.68K |
| May 19, 2025 | Marshak Richard | Chief Commercial Officer | Sell | $34.17K |
| May 19, 2025 | Stevens Jennifer | Chief Regulatory Officer | Sell | $45.09K |
| Feb 05, 2025 | Young James Emmett | Chief Financial Officer | Buy | $33.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 4 |
| 2025 Q1 | 8 | - |
| 2024 Q4 | 4 | 2 |
TLSI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools